Tuberculosis infection notification in Swiss medical students during their clinical electives

International Journal of Infectious Diseases

Volumn 7, Issue 4, 2003, Pages 268-273

  Turk, Alexander ^a,b   Angst, Felix ^a   Steffen, Robert ^a  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b NONE   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLINICAL EDUCATION; COHORT ANALYSIS; DISEASE TRANSMISSION; FEMALE; HEALTH CARE PERSONNEL; HUMAN; INCIDENCE; INFECTION RISK; MALE; MEDICAL STUDENT; MYCOBACTERIUM TUBERCULOSIS; PROSPECTIVE STUDY; QUESTIONNAIRE; SKIN INDURATION; SWITZERLAND; TUBERCULIN TEST; TUBERCULOSIS;

EID: 0346888292     PISSN: 12019712     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1201-9712(03)90105-6     Document Type: Article

References (32)

1. World Health Organization. Tuberculosis notification update. Weekly Epidemiol Rec 1996; 71:65-72.
2. Zellweger JP, Helbling P. Tuberculosis in Switzerland: from sanatorium guests to immigrants. Monaldi Arch Chest Dis 1997; 52(3):234-236.
3. Bundesamt für Gesundheit Tuberkulose in der Schweiz 1993. Bull BAG 15, 24 April 1995.
4. Massachusetts Medical Society. Tuberculosis morbidity- United States, 1997, MMWR 1998; 47(No. 13):235-238.
5. Malasky C, Jordan T, Potulski F, et al. Occupational tuberculosis infections among pulmonary physicians in training. Am Rev Respir Dis 1990; 142:505-507.
6. Brändli O. Tuberkuloseinfektion im Spital Wie können sich Mitarbeiter schützen? DIA GM 1997; 2:55-58.
7. Boudreau AY, Baron SL, Steenland NK, et al. Occupational risk of Mycobacterium tuberculosis infection in hospital workers. Am J Ind Med 1997; 32(5):528-534.
8. Sokolove PE, Mackey D, Wiles J, et al. Exposure of emergency department personnel to tuberculosis: PPD testing during an epidemic in the community. Ann Emerg Med 1994; 24:418-421.
9. Bowden KM, McDiarmid MA. Occupationally acquired tuberculosis: what's known. J Occup Med 1994; 36:320-325.
10. Schoch OD, Graf-Deuel E, Knoblauch A. Tuberculin skin testing of hospital employees: big workload with little impact. Schweiz Med Wschr 1999; 129:217-224.
11. Fagan M, Poland GA. Tuberculin skin testing in medical students. A survey of US medical schools. Ann Intern Med 1994; 120:930-931.
12. Schweizerische Vereinigung gegen Tuberkulose und Lungenkrankheiten (SVTL). Richtlinien für die Tuberkulintestierung. Bull BAG 1985; 5:42-44.
13. Sokal JE. Measurement of delayed skin-test responses. N Engl J Med 1975; 293:501-502.
14. Schweizerische Vereinigung gegen Tuberkulose und Lungenkrankheiten (SVTL). Richtlinien für die präventive Chemotherapie der Tuberkulose. Tuberkulose und Lungenkrankheiten. BAG Suppl 1991; 4:36-37.
15. Schweizerische Vereinigung gegen Tuberkulose und Lungenkrankheiten (SVTL). Richtlinien für die Tuberkulintestierung; Bull BAG 1997; 16:13-14.
16. Rosenberg T, Manfreda J, Hershfield ES. Two-step tuberculin testing in staff and residents of a nursing home. Am Rev Respir Dis 1993; 148:1537-1540.
17. Arnadottir T, Rieder HL, Trébucq A, et al. Guidelines for conducting tuberculin skin test surveys in high prevalence countries. Tuber Lung Dis 1996; 77(suppl):1-20.
18. American Thoracic Association. Diagnostic standards and classification of tuberculosis and other mycobacterial disease. Am Rev Respir Dis 1981; 123(3):343-358.
19. Menzies D. Interpretation of repeated tuberculin tests. Boosting, conversion, and reversion. Am J Respir Crit Care Med 1999; 159:15-21.
20. Baily GVJ, Narain R, Mayurnath S, et al. Trial of BCG vaccines in south India for tuberculosis prevention. Tuberculosis Prevention Trial, Madras. Ind J Med Res 1980; 72(suppl):1-74.
21. Comstock GW, Livesay VT, Woolpert SF. Evaluation of BCG vaccination among Puerto Rican children. Am J Public Health 1974; 64:283-291.
22. Comstock GW. Identification of an effective vaccine against tuberculosis. Am Respir Dis 1988; 138:479-480.
23. Horowitz HW, Luciano BB, Kadel JR, et al. Tuberculin skin test conversion in hospital employees vaccinated with bacille Calmette-Guérin: recent Mycobacterium tuberculosis infection or booster effect? Am J Infect Control 1995; 23:181-187.
24. Schweizerische Vereinigung gegen Tuberkulose und Lungenkrankheiten (SVTL). Richtlinien zur Prävention berufsbedingter Tuberkulose. Tuberkulose und Lungenkrankheiten. Bull BAG Suppl 1993; 3:25-30, 55.
25. Jeanes CWL, Davies JW, McKinnon NE. Sensitivity to 'atypical' acid-fast mycobacteria in Canada. Can Med Assoc J 1969; 100:1-8.
26. Edwards L, Acquiviva F, Livesay V, et al. An atlas of sensitivity to tuberculin and PPD-B in the United States. Am Rev Respir Dis 1969; 103:572-575.
27. Rust P, Thomas J. A method for estimating the prevalence of tuberculosis infection. Am J Epidemiol 1975; 101:311-322.
28. Rieder HL. Theroretische und praktische Überlegungen bei Anwendungen des Tuberkulintests. Pneumologie 1997; 51:1025-1032.
29. Geiseler JP, Nelson KE, Crispen RG, et al. Tuberculosis in physicians: a continuing problem. Am Rev Respir Dis 1986; 133:773-778.
30. Rieder HL. Methological issues in the estimation of the tuberculosis problem from tuberculin surveys. Tuber Lung Dis 1995; 76:114-121.
31. Sepkowitz KA. Tuberculin skin testing and the health care worker: lessons of the prophit survey. Tuber Lung Dis 1996; 77:81-85.
32. Jost M, Rüegger M, Zellweger JP, et al. Tuberkulose am Arbeitsplatz Gefährdung und Prävention. Schweiz Unfallversicherungsanstalt Abteilung Arbeitsmed 1999; 1:1-71.